CureVac

$13.39 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About CureVac

CureVac AG is a Germany-based biotechnology company. The Company is engaged in the therapeutic development of messenger Ribonucleic Acid (mRNA) and RNA-based vaccines. CureVac AG focuses on developing vaccines for infectious diseases and drugs to treat cancer and rare diseases. The Company's pipeline focuses on three areas: cancer immunotherapy, prophylactic vaccines, and protein-based therapies.

Stock Analysis

last close $13.39
1-mo return 2.3%
3-mo return -8.9%
avg daily vol. 319.91T
52-week high 75.68
52-week low 12.39
market cap. $2.6B
forward pe -
annual div. -
roe -58.8%
ltg forecast -
dividend yield -
annual rev. $137M
inst own. 22.2%
baraka

Subscribe now for daily local and international financial news

Subscribe